cervical intraepithelial neoplasia

Type: Keyphrase
Name: cervical intraepithelial neoplasia
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

The Evolving Role of HPV Testing in Cervical Cancer Screening

April 2014 Clinical Laboratory News: Volume 40, Number 4 By Timothy Uphoff, PhD, DABMG, MLS (ASCP)For decades, cervical cytology has been the mainstay of cervical cancer screening, but emerging evidence about the pathologic role of human papillomavirus ... [Published Clincial Laboratory News - Apr 04 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

I do not think that study shows what you think it shows [Respectful Insolence]

Of all the cranks, quacks, antivaccinationists, and pseudoscientists that I’ve encountered (and applied a bit of not-so-Respectful Insolence to) over the years, there are a few who belong in the top tier—or, if you prefer, the bottom tier. They stick ... [Published ScienceBlogs : Combined Feed - Apr 02 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

FDA Panel: HPV Test Can Replace Pap for Cervical Cancer Screening

Roche's HPV test could soon replace Pap smears for cervical cancer scr...The FDA Medical Devices Advisory Committee Microbiology Panel has recommended that a viral DNA test that screens for the human papillomavirus (HPV) in women can replace the standard ... [Published Cancernetwork.com - Apr 01 2014]
First reported Mar 24 2014 - Updated Mar 25 2014 - 1 reports

Anti-Interleukin-23 Monoclonal Antibody Guselkumab Shows Significant Efficacy in Treatment Of Moderate To Severe Plaque Psoriasis

“The efficacy of guselkumab in the treatment of moderate to severe plaque psoriasis looks promising according to these Phase 2b study results,” said Kristina Callis Duffin, M.D., Assistant Professor of Dermatology, University of Utah School of Medicine, ... [Published PR Newswire - Mar 24 2014]
First reported Mar 21 2014 - Updated Mar 21 2014 - 1 reports

Naturally acquired HPV16 antibodies reduced risk for infection, cervical abnormalities

New data suggest that naturally acquired HPV16 antibodies are associated with a lower risk for infection and cervical abnormalities associated with the virus. To a lesser extent, the same was true for naturally acquired HPV18 antibodies, according to ... [Published Orthopedics Today - Mar 21 2014]
First reported Mar 13 2014 - Updated Mar 13 2014 - 2 reports

FDA panel unanimously backs cobas HPV test as primary screening tool

COLLEGE PARK, MD. – A Food and Drug Administration advisory panel has unanimously supported expanding the approval of the cobas human papilloma virus test to include its use as a first-line primary cervical cancer screening test in women aged 25 years ... [Published Oncology Report - Mar 13 2014]
First reported Mar 12 2014 - Updated Mar 12 2014 - 1 reports

CEL-SCI Shares Continue To Apreciate

Shares of CEL-SCI Corporation (NYSEMKT: CVM ), have risen nearly 150% since last December, thus placing them firmly on the list of 2014's Top Healthcare Movers.Still, some argue that the firm's market cap (a mere $69M) is still undervalued and likely ... [Published BioMedReports - Mar 12 2014]
First reported Mar 11 2014 - Updated Mar 11 2014 - 1 reports

The Impact of HPV Female Immunization in Italy: Model Based Predictions

The Human Papillomavirus (HPV) is a sexually transmitted virus that causes cervical cancer. Since 2008 a vaccination program targeting 12-year-old girls has been initiated in Italy, backing up the cervical screening program already active since 1996. ... [Published PLoS medicine - Mar 11 2014]
First reported Jan 15 2014 - Updated Jan 15 2014 - 1 reports

Researchers suggest risk of cervical or vaginal cancer higher in women previously treated for precancerous cells on cer

Home » Syndicated Content » Researchers suggest risk of cervical or vaginal cancer higher in women previously treated for pre-cancerous cells on cerWomen previously treated for abnormal cells on the cervix (CIN3 or cervical intraepithelial neoplasia grade ... [Published BioPortfolio - Jan 15 2014]
First reported Jan 03 2014 - Updated Jan 03 2014 - 1 reports

Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular

Happy New Year and welcome back to the Biotech Stock Mailbag. Today marks the start of the eighth year for this column, which wouldn't be possible without your questions and comments. Thank you so much. Wayne writes: Badly eager to know your comments ... [Published The Street Latest - Jan 03 2014]
First reported Dec 19 2013 - Updated Dec 19 2013 - 1 reports

Coriolus versicolor as an Effective Addition to the Treatment of HPV Infection

Six months of treatment with Coriolus-MRL, a food supplement that contains biomass of the fungus Coriolus versicolor, is associated with a reduction in viral load in low-grade squamous intra-epithelial lesion (LSIL) patients infected with human papillomavirus ... [Published Positive Health - Dec 19 2013]

Quotes

...is for first-line primary cervical screening to detect high-risk HPV, including genotyping for genotypes 16 and 18, according to an FDA briefing . "Women who test negative for high-risk HPV types...should be followed-up in accordance with the physician's assessment of screening and medical history, other risk factors, and professional guidelines. Women who test positive for HPV genotypes 16 and/or 18 by the cobas HPV Test should be referred to colposcopy. Women who test high risk HPV positive and 16/18 negative by the cobas HPV Test (12 Other [high-risk] HPV positive) should be evaluated by cervical cytology to determine the need for referral to colposcopy."
More From BioPortfolio on "Researchers suggest risk of cervical or vaginal cancer higher in women previously treated for pre-cancerous cells on cer"

More Content

All (14) | News (11) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
[Correspondence] HPV-based screening for preven... [Published The Lancet - Apr 11 2014]
The Evolving Role of HPV Testing in Cervical Ca... [Published Clincial Laboratory News - Apr 04 2014]
I do not think that study shows what you think ... [Published ScienceBlogs : Combined Feed - Apr 02 2014]
FDA Panel: HPV Test Can Replace Pap for Cervica... [Published Cancernetwork.com - Apr 01 2014]
Anti-Interleukin-23 Monoclonal Antibody Guselku... [Published PR Newswire - Mar 24 2014]
Naturally acquired HPV16 antibodies reduced ris... [Published Orthopedics Today - Mar 21 2014]
FDA panel unanimously backs cobas HPV test as p... [Published Oncology Report - Mar 13 2014]
FDA Panel: HPV Test Before Pap for Cervical Can... [Published Diabetes Care - Mar 13 2014]
CEL-SCI Shares Continue To Apreciate [Published BioMedReports - Mar 12 2014]
The Impact of HPV Female Immunization in Italy:... [Published PLoS medicine - Mar 11 2014]
Researchers suggest risk of cervical or vaginal... [Published BioPortfolio - Jan 15 2014]
Biotech Stock Mailbag: Inovio, Chelsea, Exelixi... [Published The Street Latest - Jan 03 2014]
Coriolus versicolor as an Effective Addition to... [Published Positive Health - Dec 19 2013]
Fact Sheet for Transgene [Published Able2Act - Mar 28 2008]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
[Correspondence] HPV-based screening for preven... [Published The Lancet - Apr 11 2014]
The landmark follow-up study by Guglielmo Ronco and colleagues clearly demonstrates that high grade cervical intraepithelial neoplasia (CIN) is an excellent surrogate marker for invasive cervical cancer, strengthening the findings of the initial screening ...
I do not think that study shows what you think ... [Published ScienceBlogs : Combined Feed - Apr 02 2014]
Of all the cranks, quacks, antivaccinationists, and pseudoscientists that I’ve encountered (and applied a bit of not-so-Respectful Insolence to) over the years, there are a few who belong in the top tier—or, if you prefer, the bottom tier. They stick ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.